Data from hospital emergency departments show that every year in Europe thousands of individuals experience drug-related toxicity and other harms, resulting in emergency presentations to hospital (1). Supported by the EU drugs agency (EMCDDA), the European Drug Emergencies Network (Euro-DEN Plus) monitors drug-related emergency presentations across Europe to provide unique insight into acute health harms related to drug use (2). In the course of 2017, the network will be expanding its reach by collecting data from new hospital ‘sentinel’ centres in eight European cities........
The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the ...
Message from Wolfgang Götz, EMCDDA Director ahead of International day against drug abuse and illici...
Several thousands of cocaine-related emergencies are reported in Europe every year, representing a c...
CONTEXT: Despite the potential for recreational drugs and new psychoactive substances (NPSs) to caus...
One of the core tasks of the European Monitor Center for Drugs and Drug Addiction (EMCDDA) is to col...
One of the core tasks of the European Monitor Center for Drugs and Drug Addiction (EMCDDA) is to col...
Illicit drug use can lead to acute reverse reactions leading to the admission to emergency departmen...
One of the core tasks of the European Monitor Center for Drugs and Drug Addiction (EMCDDA) is to col...
One of the core tasks of the European Monitor Center for Drugs and Drug Addiction (EMCDDA) is to col...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-...
This report provides an update on drug-related deaths in Europe based primarily on presentations and...
Yearly contribution to the European Monitor Center for Drugs and Drug Addiction (EMCDDA) in collecti...
Introduction Novel psychoactive substances (NPS) have been increasingly reported in the last 15–20 ...
CONTEXT 3,4-Methylenedioxymethamphetamine (MDMA) remains one of the most commonly used recreation...
AIM: A central task for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is to p...
The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the ...
Message from Wolfgang Götz, EMCDDA Director ahead of International day against drug abuse and illici...
Several thousands of cocaine-related emergencies are reported in Europe every year, representing a c...
CONTEXT: Despite the potential for recreational drugs and new psychoactive substances (NPSs) to caus...
One of the core tasks of the European Monitor Center for Drugs and Drug Addiction (EMCDDA) is to col...
One of the core tasks of the European Monitor Center for Drugs and Drug Addiction (EMCDDA) is to col...
Illicit drug use can lead to acute reverse reactions leading to the admission to emergency departmen...
One of the core tasks of the European Monitor Center for Drugs and Drug Addiction (EMCDDA) is to col...
One of the core tasks of the European Monitor Center for Drugs and Drug Addiction (EMCDDA) is to col...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-...
This report provides an update on drug-related deaths in Europe based primarily on presentations and...
Yearly contribution to the European Monitor Center for Drugs and Drug Addiction (EMCDDA) in collecti...
Introduction Novel psychoactive substances (NPS) have been increasingly reported in the last 15–20 ...
CONTEXT 3,4-Methylenedioxymethamphetamine (MDMA) remains one of the most commonly used recreation...
AIM: A central task for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is to p...
The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the ...
Message from Wolfgang Götz, EMCDDA Director ahead of International day against drug abuse and illici...
Several thousands of cocaine-related emergencies are reported in Europe every year, representing a c...